Loading...
India's rivaroxaban imports from SWITZERLAND total $2.7K across 4 shipments from 1 foreign suppliers. ASAMAN INC leads with $2.7K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include MYLAN LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for rivaroxaban — a concentrated sourcing relationship with select suppliers from SWITZERLAND.
ASAMAN INC is the leading Rivaroxaban supplier from SWITZERLAND to India, with import value of $2.7K across 4 shipments. The top 5 suppliers — ASAMAN INC — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ASAMAN INC | $2.7K | 4 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $2.7K | 4 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Rivaroxaban suppliers from SWITZERLAND to India include ASAMAN INC. The leading supplier is ASAMAN INC with import value of $2.7K USD across 4 shipments. India imported Rivaroxaban worth $2.7K USD from SWITZERLAND in total across 4 shipments.
India imported Rivaroxaban worth $2.7K USD from SWITZERLAND across 4 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Rivaroxaban sourced from SWITZERLAND include MYLAN LABORATORIES LIMITED. The largest buyer is MYLAN LABORATORIES LIMITED with $2.7K in imports across 4 shipments.
The total value of Rivaroxaban imports from SWITZERLAND to India is $2.7K USD, across 4 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists